Endocrinology, Vol 132, 1497-1504, Copyright © 1993 by Endocrine Society

ARTICLES

Reciprocal modulation of interleukin-1 beta (IL-1 beta) and IL-1 receptors by lipopolysaccharide (endotoxin) treatment in the mouse brain-endocrine-immune axis

T Takao, SG Culp and EB De Souza
Central Nervous System Diseases Research, DuPont Merck Pharmaceutical Co., Wilmington, Delaware 19880-0400.

The cytokine interleukin-1 (IL-1) alters a variety of immune, central nervous system, and neuroendocrine activities characteristic of an integrator of the brain-endocrine-immune response to stress. In an attempt to define the regulation of IL-1 and IL-1 receptors in the mouse brain-endocrine-immune axis, we measured tissue levels of IL-1 beta using an enzyme-linked immunosorbent assay and iodine-125-labeled recombinant human IL-1 alpha ([125I]IL-1 alpha) binding in hippocampus, hypothalamus, pituitary, epididymus, testis, and spleen after ip injection of the bacterial endotoxin lipopolysaccharide (LPS). Basal IL- 1 beta levels were detectable in all of the tissues examined. IL-1 beta levels were dramatically increased in the peripheral tissues (pituitary, testis, and spleen) 2-6 h after a single LPS injection; however, no significant changes were observed in the brain (hippocampus and hypothalamus). [125I]IL-1 alpha binding was decreased in the spleen, but was unchanged in the hippocampus and testis after a single LPS injection. To determine whether activation of IL-1 in brain may require more sustained exposure to endotoxin, we examined the effects of two injections of LPS at 0 and 12 h. After two LPS injections (0 and 12 h), significant increases in IL-1 beta concentrations were noted in the hippocampus, hypothalamus, spleen, testis and epididymus; [125I]IL- 1 alpha binding using quantitative autoradiography was significantly decreased in all tissues, including the pituitary gland. Saturation studies in whole testis homogenates demonstrated that the LPS-induced decrease in [125I]IL-1 alpha binding was primarily due to a decrease in the density of IL-1 receptors. These data demonstrate that LPS treatment results in elevated circulating and/or tissue levels of IL-1, which, in turn, down-regulates IL-1 receptors in the brain-endocrine- immune axis.

This article has been cited by other articles:

				M. K. O'Bryan, O. Gerdprasert, D. J. Nikolic-Paterson, A. Meinhardt, J. A. Muir, L. M. Foulds, D. J. Phillips, D. M. de Kretser, and M. P. Hedger Cytokine profiles in the testes of rats treated with lipopolysaccharide reveal localized suppression of inflammatory responses Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1744 - R1755. [Abstract] [Full Text] [PDF]

				V. Morales, P. Santana, R. Diaz, C. Tabraue, G. Gallardo, F. L. Blanco, I. Hernandez, L. F. Fanjul, and C. M. Ruiz de Galarreta Intratesticular Delivery of Tumor Necrosis Factor-{alpha} and Ceramide Directly Abrogates Steroidogenic Acute Regulatory Protein Expression and Leydig Cell Steroidogenesis in Adult Rats Endocrinology, November 1, 2003; 144(11): 4763 - 4772. [Abstract] [Full Text] [PDF]

				S. Laye, G. Gheusi, S. Cremona, C. Combe, K. Kelley, R. Dantzer, and P. Parnet Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R93 - R98. [Abstract] [Full Text] [PDF]

				M. K. O'Bryan, S. Schlatt, D. J. Phillips, D. M. de Kretser, and M. P. Hedger Bacterial Lipopolysaccharide-Induced Inflammation Compromises Testicular Function at Multiple Levels in Vivo Endocrinology, January 1, 2000; 141(1): 238 - 246. [Abstract] [Full Text] [PDF]

				J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434. [Abstract] [Full Text]

				L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF]

				M. van Deuren, J. van der Ven-Jongekrijg, E. Vannier, R. van Dalen, G. Pesman, A. K.M. Bartelink, C. A. Dinarello, and J. W.M. van der Meer The Pattern of Interleukin-1beta (IL-1beta ) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections Blood, August 1, 1997; 90(3): 1101 - 1108. [Abstract] [Full Text] [PDF]

				C. Cudicini, H. Lejeune, E. Gomez, E. Bosmans, F. Ballet, J. Saez, and B. Jegou Human Leydig Cells and Sertoli Cells Are Producers of Interleukins-1 and -6 J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1426 - 1433. [Abstract] [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]

				C. Liu, R. P. Hart, X.-J. Liu, W. Clevenger, R. A. Maki, and E. B. De Souza Cloning and Characterization of an Alternatively Processed Human Type II Interleukin-1 Receptor mRNA J. Biol. Chem., August 23, 1996; 271(34): 20965 - 20972. [Abstract] [Full Text] [PDF]